Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. ProMIS Neurosciences Inc shares valued at $14,595 were purchased by Cashman Neil on Feb 10 ’25. At $0.97 per share, Cashman Neil acquired 15,000 shares. The insider’s holdings grew to 16,617 shares worth approximately $13958.279999999999 following the completion of this transaction.
Also, Shafmaster Madge K. purchased 70,000 shares, netting a total of over 91,028 in proceeds. Following the buying of shares at $1.30 each, the insider now holds 208,333 shares.
Before that, Shafmaster Madge K. had added 70,000 shares to its account. In a trade valued at $89,656, the Director bought ProMIS Neurosciences Inc shares for $1.28 each. Upon closing the transaction, the insider’s holdings increased to 70,000 shares, worth approximately $0.12 million.
Analyzing PMN Stock Performance
On last trading session,, ProMIS Neurosciences Inc [NASDAQ: PMN] rose 0.52% to $0.84. The stock’s lowest price that day was $0.8181, but it reached a high of $0.89 in the same session. During the last five days, there has been a drop of approximately -4.02%. Over the course of the year, ProMIS Neurosciences Inc shares have dropped approximately -47.22%.
Support And Resistance Levels for ProMIS Neurosciences Inc (PMN)
RSI (Relative Strength Index) is 59.38 on the 14-day chart, showing neutral technical sentiment.
Is ProMIS Neurosciences Inc subject to short interest?
Stocks of ProMIS Neurosciences Inc saw a sharp rise in short interest on 2025-07-15 jumping by 1.63 million shares to 1.77 million. Data from Yahoo Finance shows that the short interest on 2025-06-13 was 0.14 million shares. A jump of 92.0% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 0.35 of the overall float, the days-to-cover ratio (short ratio) jumped to 0.35.
Which companies own the most shares of ProMIS Neurosciences Inc (PMN)?
In terms of ProMIS Neurosciences Inc share price expectations, FactSet research, analysts set an average price target of 4 in the next 12 months, up nearly 376.19% from the previous closing price of $0.84. Analysts anticipate ProMIS Neurosciences Inc stock to reach 4 by 2025, with the lowest price target being 4.
